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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S140Figure - Effect of IL 1b mAb on cartilage proteoglycan synthesis rate (A)
and – release (B). Median values  IQR of 6 individual cartilage and blood
donors are shown. Hash tags indicate a statistically signiﬁcant difference
from control values, whereas asterisks indicate a statistically signiﬁcant
difference from blood-exposed cartilage without IL 1b mAb addition (p <
0.05).
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CONCENTRATION DEPENDENT CARTILAGE BOUNDARY LUBRICATING
ABILITY OF PROTEOGLYCAN 4 MONOMERS AND MULTIMERS
S. Abubacker, T.A. Schmidt. Univ. of Calgary, Calgary, AB, Canada
Purpose: Proteoglycan 4 (PRG4) is a mucin-like glycoprotein that exists
in synovial ﬂuid (SF) as monomeric (PRG4-mono) and multimeric
(PRG4-multi) forms. PRG4 is present at the surface of articular cartilage
where it functions as a critical boundary lubricant in a dose-dependent
manner, and is necessary for joint health. The ability to form disulﬁde-
bonded multimers is a functionally determinant property for many
mucins, and this appears to be true for PRG4.We have previously shown
that PRG4-multi is a more effective cartilage boundary lubricant com-
pared to PRG4-mono at the same physiological concentration (450 mg
/mL), suggesting inter-molecular disulﬁde bonds are important for
boundary lubrication function. However, the potential dose-depend-
ence of PRG4-multi’s and PRG4-mono’s cartilage boundary lubricating
ability remains unknown. Therefore, the objective of this study was to
analyse the cartilage boundary lubricating ability of PRG4-mono and
PRG4-multi over a range of pathophysiological concentrations.
Methods: PRG4 was puriﬁed frommedia conditioned bymature bovine
cartilage explants. Enriched non-reduced PRG4-mono and -multi were
prepared using size exclusion chromatography (SEC) (Sephacryl S-500,
XK16/100 column) with PBSþ0.25%CHAPS. The cartilage boundary
lubricating ability of the enriched preparations was assessed using an in
vitro cartilage-cartilage friction test under boundary lubricating con-
ditions. Kinetic (< mkinetic,Neq>) friction coefﬁcient were then
calculated.
Test sequences:
PRG4-mono dose-response (n ¼ 4): PBS, 45 mg/mL, 150 mg/mL, 450 mg/
mL, SF
PRG4-multi dose-response (n ¼ 4): PBS, 45 mg/mL, 150 mg/mL, 450 mg/
mL, SF
Statistical Analysis: Data are presented as mean  SEM. ANOVA was
used to assess the effect of lubricant and pre-sliding duration (Tps), as a
repeated factor, on < mkinetic,Neq> with Fisher’s post-hoc testing at
Tps ¼ 1.2s on PRG4-multi and -mono dose-responses.
Results: < mkinetic,Neq> values for both PRG4-mono and -multi varied
with lubricant and Tps (both p < 0.05) increasing only slightly with Tps,
with no interaction (both p > 0.05). < mkinetic,Neq> values at Tps ¼
1.2s for PRG4-mono at 45 mg/mL (0.159  0.022), 150 mg/mL (0.142 
0.014) and 450 mg/mL (0.145  0.027) were not signiﬁcantly different
from each other (p> 0.05). However, PRG4-multi at 450 mg/mL (0.090
0.007) was signiﬁcantly lower than PRG4-multi at 45 mg/mL (0.163 
0.023, p < 0.01) and 150 mg/mL (0.144  0.011, p < 0.05). There was no
signiﬁcant difference between PRG4-multi at 45 mg/mL and 150 mg/mL
(p > 0.05) (Fig.1).
Conclusions: These results indicate PRG4’s disulﬁde bonded multi-
meric structure contributes to its ability to function as a dose-
dependent cartilage boundary lubricant, and is consistent with higher
order protein structure and disulﬁde bonding being necessary for
PRG4’s cartilage boundary lubricating ability. Interestingly, PRG4-mono
and PRG4-multi had similar boundary lubricating ability at the lower
(45, 150 mg/mL) concentrations. However, PRG4-mono at 450 mg/mL didnot further reduce friction compared to 150 mg/mL, whereas PRG4-
multi did and also possessed similar lubricating ability to that of whole
PRG4 at the physiological concentration of 450 mg/mL. Future studies
are required to determine the role these properties play in PRG4’s
ability to synergistically interact with hyaluronan to further lower
friction to levels near that of whole SF.
Signiﬁcance: Elucidating the PRG4 structure-lubrication function
relationship, both alone and with other SF constituents such as hya-
luronan, will further contribute to the understanding of PRG4’s role in
diarthrodial joint homeostasis and disease.
Figure 1. < mkinetic,Neq> friction coefﬁcients at Tps ¼ 1.2 s of PRG4-
mono and PRG4-multi at 45, 150 and 450 mg/mL. Where * is p < 0.01 and
** is p < 0.05 for PRG4-multi. There are no signiﬁcant differences across
the different concentrations for PRG4-mono. (ANOVA with Fisher’s post-
hoc). Sample size, n ¼ 4–8.
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ELIMINATION OF BMP7 EXPRESSION FROM THE LIMB ENHANCES
ARTICULAR CARTILAGE DEGENERATION AND SYNOVIAL
HYPERPLASIA IN ADULT MICE
K. Abula y, T. Muneta y, K. Miyatake y, J. Yamada y, Y. Matsukura y,
M. Inoue z, I. Sekiya x, D. Graf k, A. Economides{, V. Rosen#, K. Tsuji yy.
yDept. of Joint Surgery and Sports Med., Tokyo Med. and Dental Univ.,
Tokyo, Japan; zDept. of Plastic Reconstructive and Aesthetic Surgery,
Tokyo Med. and Dental Univ., Tokyo, Japan; xCtr. for Stem Cell and
Regenerative Med. , Tokyo Med. and Dental Univ., Tokyo, Japan; k Inst. of
Immunology, BioMed. Sci. Res. Ctr., Athens, Greece; {Regeneron
Pharmaceuticals, Inc, Tarrytown, NY, USA; #Dept. of Dev.al Biology,
Harvard Sch. of Dental Med., Boston, MA, USA; yyDept. of Cartilage
Regeneration, Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: While the potentials of recombinant bone morphogenetic
protein 7 (rhBMP7) in articular cartilage homeostasis are well recog-
nized through its anabolic, anti-apoptotic, anti-catabolic and anti-
inﬂammatory effects, analyses of the physiological roles of endogenous
Bmp7 has been hampered by the perinatal lethality of Bmp7 knockout
mice due to the kidney defect. To overcome these problems, we
employed conditional deletion of Bmp7 from the limb prior to the onset
of skeletogenesis during embryonic development. In this study, we
showed that endogenous Bmp7 has important roles for the joint
homeostasis.
Methods: Limb speciﬁc Bmp7 conditional knockout (:7CKO) mice were
created by breeding the mice carrying ﬂoxed Bmp7 with Prx1::cre
transgenic mice. Littermates those do not carry cre recombinase were
designated as control (Cont) mice. Whole knee joints of :7CKO and Cont
micewere harvested at 4 (n¼ 3 each), 8 (n¼ 7 each) and 24 (n¼ 9 each)
weeks of age. For the histological analyses, sagittal sections of the knee
joint were stained with safranin O-fast green or Hematoxylin and Eosin
(H/E). The severity of cartilage degeneration was evaluated by modiﬁed
Mankin’s score system. The severity of synovitis was evaluated by
synovitis score system. Articular cartilage structure such as thickness
and chondrocyte number was analyzed by Zeiss Axiovision Image
analysis system. For the immunohistochemical analyses, anti-mouse
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S141type-II collagen antibody (Abcam) and F4/80 (AbD Serotec) were used.
Cell death inside articular cartilage was examined by TUNEL assay.
Expression of catabolic, inﬂammatory, and anabolic factors such as
MMP3, MMP13, cathepsin F, IL1b, IL6, type II collagen and type X col-
lagen mRNA in cartilagious tissues of :7CKO and Cont mice was quan-
titated by Q-PCR.
Results: In this study, we found that the absence of locally produced
Bmp7 reduced proteoglycan contents in articular cartilage matrix in the
adult mice (at 8 and 24 weeks of age). This may not be due to the defect
in cartilage formation since there was no signiﬁcant alteration in both
articular structure and proteoglycan contents in the juvenile :7CKO
mice (at 4 weeks of age). Structural analyses of articular cartilage
indicated that cartilage thickness and chondrocyte density were not
signiﬁcantly altered between the genotypes at 8 and 24 weeks of age.
TUNEL assay revealed that elimination of Bmp7 expression did not
affect chondrocyte survival at 8 weeks of age. Histological evaluation
revealed that extensive synovial hyperplasia was observed at 8 and 24
weeks of age in the absence of Bmp7. F4/80 staining revealed that
extensive numbers of macrophages were inﬁltrated in the synovial
tissues of :7CKO mice at these stages suggesting that severe synovitis
occurred in the absence of Bmp7. In contrast, appearance of synovial
membrane was quite similar between the genotypes at 4 weeks of age.
Q-PCR analyses revealed that mRNA expression levels of all the genes
examined (see above) in articular cartilage were not signiﬁcantly
altered between the genotypes at 24 weeks of age.
Conclusions: Our data showed that the absence of endogenous Bmp7,
although does not affect articular cartilage formation and survival of
articular chondrocyte, but enhance articular cartilage degeneration and
synovial inﬂammation in adult mice.
226
EPIGENETIC MODIFYING COMPOUNDS ALTER ACTIVITY OF PRIMARY
HUMAN ARTICULAR CHONDROCYTES AND MESENCHYMAL STEM
CELLS UNDERGOING CHONDROGENESIS
S. Snelling, A. Kramm, C. Yapp, A. Carr, U. Oppermann. Univ. of Oxford,
Oxford, United Kingdom
Purpose: A major therapeutic challenge in osteoarthritis is to identify
disease modifying therapeutics. No current therapies cause cessation or
reversal of cartilage loss. Suitable therapeutics may target the chon-
drocytes or stem cells resident within the diseased cartilage or expan-
ded in vitro prior to implantation. Epigenetic regulation of cell behavior
is essential for both correct development and homeostasis of cartilage
(1). This epigenetic control does not alter the DNA sequence and allows
modiﬁable changes to gene expression that are heritable. Thus allowing
a cell to respond to environmental and biological cues. Targeting the
epigenetic modifying machinery can therefore provide important clues
to the biology of chondrocyte differentiation and homeostasis and to
potential targets for therapeutic intervention.
Our library of epigenetic modifying compounds includes those target-
ing methyltrasnferases, histone deacetylases, histone protein kinases
and bromodomains. In this preliminary work we have screened this
library for impact on cell phenotype in chondrogenesis and in primary
human articular chondrocytes (HAC)
Methods: Primary human articular chondrocytes (HAC) and human
mesencymal stem cells (MSCs) undergoing chondrogenesis were trea-
ted with epigenetic modifying compounds for 72 hours. Metabolic
activity was assessed after 72h using Prestoblue before cells were ﬁxed
and assessed for cell number (DAPI count), ECM production (Alcian
blue) and nodule formation (Nile Red). HAC were treated with GSK-J4
and GSK-J5 for 6h and TIMP3 and COL2A1 expression assessed by qPCR.
HAC were treated with GSK-J4 and GSK-J5 for 3h in the presence and
absence of 2ng/ml TGFb and expression JMJD3 and the TGFb target gene
TIMP3 was assssed by qPCR.
Results: Compounds including Methylstat, an inhibitor of the Jumonji C
domain-containing histone trimethyl demethylases caused an increase
in the metabolic activity and cell number of MSCs and HAC, whilst 5-
iodotubercidin increasedmetabolic activity inMSCs only. GSK-J4, which
blocks H3K27 demethylation decreased metabolic activity and cell
number in MSCs and HAC. ECM accumulation in chondrogenesis were
reduced by compounds including GSK-J4 whilst ECM accumulation was
increased by the PARP inhibitor Rucaparib.
COL2A1 and TIMP3 expressionwas reduced in HAC treated with GSK-J4,
but not HAC treated with the inactive isomer GSK-J5. Treatment of HAC
with TGFb increased the expression of the H3K27 demethylase JMJD3and the TGF-responsive gene TIMP3. In the presence of GSK-J4 the TGF-
induced JMJD3 and TIMP3 expression was inhibited.
Conclusions: This preliminary screen demonstrates the utility of epi-
genetic modifying compounds in the regulation of chondrogenesis and
HAC behavior. We have shown that epigenetic regulation can both
enhance and inhibit chondrogenesis and can also alter the phenotype of
HAC. The differential effects of compounds in HAC and MSC indicates
the importance of ﬁne and temporally correct regulation of epigenetic
activities during chondrocyte differentiation and homeostasis. Early
investigations on the role of GSK-J4, which inhibits the histone deme-
thylase JMJD3, in HAC suggest JMJD3 as an important epigenetic target
through its ability to regulate TGFb signaling.
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FIBRILLIN-1 EXPRESSION, WHICH REGULATES OF TGF-B
BIOAVAILABILITY, IS MODIFIED DURING OSTEOARTHRITIS AND
MUTATIONS LEAD TO OSTEOARTHRITIS
W. Ramanayake y, H. Jones z, I. Orriss x, T. Arnett y, A. Pitsillides x,
C. Denton y, D. Abraham y, B. Poulet y. yUniv. Coll. London, London, United
Kingdom; zUCL, London, United Kingdom; xRoyal Vet. Coll., London,
United Kingdom
Purpose: The TGFb signalling pathway has been shown to play a major
role in joint homeostasis and in osteoarthritis development. Fibrillin-1
is an extracellular matrix protein that may play a structural role in the
matrix of articular cartilage. Fibrillin rich microﬁbrils (especially
ﬁbrillin-1) help in the regulation of TGFb activity by controlling its
bioavailability to the cell. Thus Fibrillin-1 mutations, such as those
seen in the Tight Skin mouse (or TSK), have been shown to increase
TGFb signalling. The TSK mouse displays tight skin, myocardial
hypertrophy, marfan-like skeletal phenotype and lung emphysema,
but no studies have yet investigated the effect of Fibrillin-1 mutation
on joint health. The aim of this study is therefore to determine
changes in ﬁbrillin-1 expression during osteoarthritis in mice and to
characterise the effect of Fibrillin-1 mutations in ageing-induced OA
development in TSK mice.
Methods: Immunohistochemistry for Fibrillin-1 expression was per-
formed in Str/ort mice, a known model of spontaneous OA, and in
control aged-matched non-OA CBA mice, in knee joints with different
degrees of OA severity. The knees of TSK and littermate control male
mice of 60-80wks of age were ﬁxed and microCT scanned. Abnormal
ectopic calciﬁed regions were analysed. After scanning, joints were
decalciﬁed and processed for parafﬁn embedding; serial coronal sec-
tions were cut at 6um and sections at regular intervals stained with
Toluidine Blue.
Results: Fibrillin-1 was localised in the pericellular matrix of articular
chondrocytes in normal joints. During the development of OA in Str/ort
mice, however, Fibrillin-1 immunolabelling was decreased, in particular
around articular cartilage lesions. TSK mice microCT images showed
important ectopic calciﬁcation and ossiﬁcation in various ligaments,
including patella and collateral ligaments, as well as osteophyte for-
mation on the margins of the joints. Preliminary data suggest that
articulate cartilage degradation was increased in TSK mice compared to
aged-matched control mice suggesting a role of Fibrillin-1 in joint
health and osteoarthritis development.
Conclusion: Our preliminary study shows that Fibrillin-1 protein
expression is decreased during OA development in a well knownmodel
of spontaneous OA, suggesting TGFb bioavailability may be modiﬁed
during this period. In addition, mutations in Fibrillin-1 in the TSK
mouse lead to abnormal ossiﬁcation in the knee joint as well as severe
OA development. These data suggest that Fibrillin-1 plays an important
role in joint homeostasis and that abnormal expression or mutations in
its gene can lead to OA development.
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DYNAMIC CHANGES OF EXTRA CELLULAR MATRIX PROTEINS IN
EQUINE ARTICULAR CARTILAGE TREATED WITH INTERLEUKIN-1B
IN VITRO
E. Svala y,z, M. L€ofgren y, C. Sihlbom x, U. R€uetschi y, A. Lindahl y,
S. Ekman y, E. Ski€oldebrand y,z. , Major contributor: late Professor Dick
HeinegardyBioMed. Sci. and Vet. Publ. Hlth., Swedish Univ. of Agricultural
Sci., Uppsala, Sweden; z Inst. of Biomedicine, Sahlgrenska Univ. Hosp.,
Gothenburg Univ., Gothenburg, Sweden; x Proteomics Core Facility,
Sahlgrenska Academy,Univ. of Gothenburg, Gothenburg, Sweden
